Jane Henderson has sold stock and made no open-market buys since Mar 2018

Jane Pritchett Henderson is the Chief Financial Officer of Apogee Therapeutics, Inc. (NASDAQ: APGE), a role she has held since January 2023.( A veteran life sciences finance executive, she brings more than two decades of healthcare investment banking and senior corporate finance experience to Apogee, overseeing the company’s financial strategy and capital markets activities.( In addition to her Apogee role, she serves as an independent director on the boards of companies such as Akero Therapeutics and Ventus Therapeutics, reflecting her broader governance and strategic advisory experience across the biopharmaceutical sector.(

Before joining Apogee, Henderson held senior finance and corporate development positions at multiple biotechnology companies, including Invivyd (formerly Adagio Therapeutics), Turnstone Biologics, Voyager Therapeutics, Kolltan Pharmaceuticals, and ISTA Pharmaceuticals, where she led financing, M&A, and business development initiatives.( Earlier in her career she spent roughly 20 years in healthcare investment banking, executing more than 95 mergers, acquisitions, and financing transactions in senior roles at firms such as HSBC, CIBC, Lehman Brothers, and Salomon Brothers.( Henderson holds a B.S. in psychology from Duke University.(

Written by Perplexity from public sources.